Susanna Passetti

Susanna Passetti

Auto-generated profile, based on publicly available information

Susanna Passetti

Otology-Cochlear Implant Centre, Department of Neuroscience, University of Pisa

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2010 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
PDF file
Luca BruschiniLuca Bruschini
Luca Bruschini
FFFrancesca Forli
Francesca Forli
SPSusanna Passetti
Susanna Passetti
PBPaolo Bruschini
Paolo Bruschini
SBStefano Berrettini
Stefano Berrettini
Conclusion: Our results attest that the Otologics MET Carina™ is a viable treatment for moderate to severe sensorineural hearing loss (SNHL) and for cases of mixed hearing loss, and that in selected cases it could represent an alternative to conventional hearing aids. Objectives: To describe our experience with the fully implantable Carina™ in eight adult patients, seven with moderate to severe SNHL and one with mixed hearing loss. Methods: Eight implanted adult patients were submitted to a comprehensive audiological evaluation. Results: We did not record any surgical relevant complication in any of the patients, nor any significant postoperative variation in hearing thresholds, for air conduction or bone conduction, indicating the absence of surgical damage to the cochlea. All the patients demonstrated improvements in speech perception abilities with the device functioning and reported subjective benefits. With regard to the postoperative adverse effects, we had problems with feedback noise, which resolved with minor fitting adjustments in seven cases, while it required a second surgery to change the microphone position in the other patient. In one case a minimal extrusion of the microphone cable occurred requiring a revision surgery, a device failure occurred in one case, requiring substitution, and one patient decided on explantation of the device owing to psychological problems.

1 August 2007 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
SBSTEFANO BERRETTINI
STEFANO BERRETTINI
FFF Forli
F Forli
SPS Passetti
S Passetti
The preservation of residual hearing is becoming a high priority in cochlear implant surgery. It allows better speech understanding and ensures long-lasting and stable performance; it also allows the possibility, in selected cases, of combining electro-acoustic stimulation in the same ear.We present the results of a retrospective study of the conservation of residual hearing in three different groups of patients who had undergone cochlear implantation using three different cochlear implant electrode arrays, combined with three different surgical techniques for the cochleostomy. The study aimed to evaluate which approach allowed greater preservation of residual hearing.The best residual hearing preservation results (i.e. preservation in 81.8 per cent of patients) were achieved with the Contour Advance electrode array, using the Advance Off-Stylet technique and performing a modified anterior inferior cochleostomy; this combination enabled reduced trauma to the lateral wall of the cochlea during electrode insertion.

1 February 2008 in Bioscience Reports
Verified
Journal Article
Closed access
PDF file
SBSTEFANO BERRETTINI
STEFANO BERRETTINI
FFFrancesca Forli
Francesca Forli
SPSusanna Passetti
Susanna Passetti
ARAnna Rocchi
Anna Rocchi
LPLuca Pollina
Luca Pollina
GSGabriele Siciliano
Gabriele Siciliano
Over the last decade, a number of distinct mutations in the mtDNA (mitochondrial DNA) have been found to be associated with both syndromic and non-syndromic forms of hearing impairment. Their real incidence as a cause of deafness is poorly understood and generally underestimated. Among the known mtDNA mutations, the A1555G mutation in the 12S gene has been identified to be one of the most common genetic cause of deafness, and it has been described to be both associated to non-syndromic progressive SNHL (sensorineural hearing loss) and to aminoglycoside-induced SNHL. In the present study, we have investigated the presence of mtDNA alterations in patients affected by idiopathic non-syndromic SNHL, both familiar and sporadic, in order to evaluate the frequency of mtDNA alterations as a cause of deafness and to describe the audiological manifestations of mitochondrial non-syndromic SNHL. In agreement with previous studies, we found the A1555G mutation to be responsible for a relevant percentage (5.4%) of cases affected with isolated idiopathic sensorineural hearing impairment.

1 September 2010 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
SBSTEFANO BERRETTINI
STEFANO BERRETTINI
SPSusanna Passetti
Susanna Passetti
MGMichela Giannarelli
Michela Giannarelli
FFFrancesca Forli
Francesca Forli

13 June 2007 in Bioscience Reports
Verified
Journal Article
Closed access
PDF file
FFF. Forli
F. Forli
SPS. Passetti
S. Passetti
MMM. Mancuso
M. Mancuso
VSV. Seccia
V. Seccia
GSG. Siciliano
G. Siciliano
SBS. Berrettini
S. Berrettini
Mitochondrial diseases (MD) are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. Sensorineural hearing loss (SNHL) is often associated to mitochondrial dysfunctions both in syndromic, nonsyndromic forms. SNHL has been described in association to different mitochondrial multisystemic syndromes, often characterized by an important neuromuscular involvement. Because of the clinical relevance of the associated neurological symptoms, the occurrence of SNHL is often underestimated and undiagnosed. In this study we evaluated the incidence of SNHL in a group of 17 patients with MD. We detected some degree of hearing impairment in 8/17 patients (47%), thus confirming the frequency of hearing impairment in MD. Furthermore, we want to highlight the role of the audiologist and otolaryngologist in the diagnosis and characterization of a MD, which should be suspected in all the cases in which the hearing loss is associated to signs and symptoms characteristic of mitochondrial dysfunction, especially if the family history is positive for hearing loss or MD in the maternal line.

1 January 2009 in Audiological Medicine
Verified
Journal Article
Closed access
PDF file
FFFrancesca Forli
Francesca Forli
SPSusanna Passetti
Susanna Passetti
ENEmanuele Neri
Emanuele Neri
DGDonato Gianfelice
Donato Gianfelice
SBSTEFANO BERRETTINI
STEFANO BERRETTINI
Sensorineural hearing loss (SNHL) has been rarely reported in neurofibromatosis type 1 (NF type 1) and literature data concerning its pathogenesis are lacking. We report a patient affected by NF type 1, who several years later developed Cogan's syndrome, with a quickly progressive bilateral SNHL, leading to total deafness. Cochlear implantation was carried out in a partially ossified cochlea, with a good outcome. On the basis of our findings, we underscore the importance of comprehensive evaluation of patients with NF type 1 who develop SNHL, to accurately evaluate the pathogenesis of the hearing loss and explore other possible causes of hearing impairment especially with the emergence of new symptoms. If a retrocochlear lesion is excluded, a cochlear implantation is a viable option for those NF type 1 patients who develop a severe to profound SNHL. We also highlight the importance of a prompt and accurate radiological study of the petrous bone in patients with Cogan's syndrome considered for cochlear implantation, in order to plan a proper surgical approach and the importance of a thorough post-implant medical follow-up.